Abstract Details

Title The safety and efficacy of Rituximab Use in Secondary-Progressive Multiple Sclerosis (SPMS) at UMMHC: five years follow up data

Topic Multiple Sclerosis

Presentation(s) P5 - (-)

Poster/Presentation
Number 408

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Idanis Berrios Morales, MD (University of Massachusetts Medical School) PRESENTER	Dr. Berrios Morales has nothing to disclose.
Evdokia Eleftheriou, MD (Maine Medical Partners Neurology)	No disclosure on file
	No disclosure on file
	No disclosure on file
Carolina Ionete, MD (UMass Memorial)	Dr. Ionete has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from Biogen. The institution of Dr. Ionete has received research support from NIH.